These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28186666)

  • 21. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
    Marras C; Alcalay RN; Caspell-Garcia C; Coffey C; Chan P; Duda JE; Facheris MF; Fernández-Santiago R; Ruíz-Martínez J; Mestre T; Saunders-Pullman R; Pont-Sunyer C; Tolosa E; Waro B;
    Mov Disord; 2016 Aug; 31(8):1192-202. PubMed ID: 27091104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased facilitation of the primary motor cortex in de novo Parkinson's disease.
    Shirota Y; Ohminami S; Tsutsumi R; Terao Y; Ugawa Y; Tsuji S; Hanajima R
    Parkinsonism Relat Disord; 2019 Sep; 66():125-129. PubMed ID: 31327628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
    Dzamko N; Rowe DB; Halliday GM
    Mov Disord; 2016 Jun; 31(6):889-97. PubMed ID: 26917005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of long term potentiation-like plasticity in primary motor cortex in patients with progressive supranuclear palsy.
    Bologna M; Bertram K; Paparella G; Papi C; Belvisi D; Conte A; Suppa A; Williams DR; Berardelli A
    Clin Neurophysiol; 2017 Sep; 128(9):1547-1552. PubMed ID: 28704733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine influences primary motor cortex plasticity and dorsal premotor-to-motor connectivity in Parkinson's disease.
    Suppa A; Iezzi E; Conte A; Belvisi D; Marsili L; Modugno N; Fabbrini G; Berardelli A
    Cereb Cortex; 2010 Sep; 20(9):2224-33. PubMed ID: 20051362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced cortical plasticity and GABAergic modulation in essential tremor.
    Chuang WL; Huang YZ; Lu CS; Chen RS
    Mov Disord; 2014 Apr; 29(4):501-7. PubMed ID: 24449142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Daniele A; Ghirlanda S; Gainotti G; Tonali PA
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):555-9. PubMed ID: 15026495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease.
    Suppa A; Marsili L; Belvisi D; Conte A; Iezzi E; Modugno N; Fabbrini G; Berardelli A
    Exp Neurol; 2011 Feb; 227(2):296-301. PubMed ID: 21145888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional reorganization of sensorimotor cortex in early Parkinson disease.
    Kojovic M; Bologna M; Kassavetis P; Murase N; Palomar FJ; Berardelli A; Rothwell JC; Edwards MJ; Bhatia KP
    Neurology; 2012 May; 78(18):1441-8. PubMed ID: 22517098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
    Chou JS; Chen CY; Chen YL; Weng YH; Yeh TH; Lu CS; Chang YM; Wang HL
    Neurobiol Dis; 2014 Aug; 68():190-9. PubMed ID: 24830390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.
    Koch G; Brusa L; Carrillo F; Lo Gerfo E; Torriero S; Oliveri M; Mir P; Caltagirone C; Stanzione P
    Neurology; 2009 Jul; 73(2):113-9. PubMed ID: 19597133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study.
    Strafella AP; Valzania F; Nassetti SA; Tropeani A; Bisulli A; Santangelo M; Tassinari CA
    Clin Neurophysiol; 2000 Jul; 111(7):1198-202. PubMed ID: 10880793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracortical inhibition of the motor cortex in Segawa disease (DYT5).
    Hanajima R; Nomura Y; Segawa M; Ugawa Y
    Neurology; 2007 Mar; 68(13):1039-44. PubMed ID: 17389309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson's disease.
    Guerra A; Asci F; Zampogna A; D'Onofrio V; Suppa A; Fabbrini G; Berardelli A
    Brain Stimul; 2022; 15(1):99-108. PubMed ID: 34823038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor cortex plasticity can indicate vulnerability to motor fluctuation and high L-DOPA need in drug-naïve Parkinson's disease.
    Kishore A; James P; Krishnan S; Yahia-Cherif L; Meunier S; Popa T
    Parkinsonism Relat Disord; 2017 Feb; 35():55-62. PubMed ID: 28003105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
    Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease.
    Guerra A; Suppa A; D'Onofrio V; Di Stasio F; Asci F; Fabbrini G; Berardelli A
    Brain Stimul; 2019; 12(6):1517-1525. PubMed ID: 31217080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.